FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

416375002: Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3762275019 Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3762276018 Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2546585011 Loteprednol etabonate 0.5%/tobramycin 0.3% ophthalmic suspension (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2546585011 Loteprednol etabonate 0.5%/tobramycin 0.3% ophthalmic suspension (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2548884010 Loteprednol etabonate 0.5%/tobramycin 0.3% ophthalmic suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2548884010 Loteprednol etabonate 0.5%/tobramycin 0.3% ophthalmic suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3762275019 Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3762276018 Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a Loteprednol etabonate + tobramycin false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tobramycin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Loteprednol etabonate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a Loteprednol etabonate ophthalmic preparation (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a Product containing tobramycin in ophthalmic dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has manufactured dose form Eye suspension true Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a Product containing loteprednol and tobramycin (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a Product containing loteprednol in ocular dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator unit (attribute) Milliliter (qualifier value) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator unit mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator unit (attribute) Milliliter (qualifier value) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator unit mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a Product containing only loteprednol and tobramycin in ocular dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has precise active ingredient Loteprednol etabonate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has precise active ingredient Tobramycin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has basis of strength substance (attribute) Tobramycin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator value cinq false Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator value trois false Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has basis of strength substance (attribute) Loteprednol etabonate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Plays role Antibacterial therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start